Labrador, Jovie D.

HRN: 22-55-02  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/27/2023
CEFUROXIME 1.5GM (VIAL)
01/27/2023
01/28/2023
IV
Q8
Q8
LTCS
Waiting Final Action 
01/27/2023
CEFUROXIME 1.5GM (VIAL)
01/27/2023
01/29/2023
IV
1.5 G
Q8 X 6 Doses
Sp LTCS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: